Bausch Health Companies Inc (NYSE: BHC): Reassessing Prospects

Bausch Health Companies Inc (BHC) concluded trading on Wednesday at a closing price of $10.04, with 6.74 million shares of worth about $67.64 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 23.34% during that period and on April 3, 2024 the price saw a loss of about -1.57%. Currently the company’s common shares owned by public are about 365.24M shares, out of which, 356.60M shares are available for trading.

Stock saw a price change of 1.83% in past 5 days and over the past one month there was a price change of 4.80%. Year-to-date (YTD), BHC shares are showing a performance of 25.19% which increased to 23.95% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $5.57 but also hit the highest price of $10.80 during that period. The average intraday trading volume for Bausch Health Companies Inc shares is 2.41 million. The stock is currently trading 4.70% above its 20-day simple moving average (SMA20), while that difference is up 12.22% for SMA50 and it goes to 22.57% higher than SMA200.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Bausch Health Companies Inc (NYSE: BHC) currently have 365.24M outstanding shares and institutions hold larger chunk of about 79.14% of that.

The stock has a current market capitalization of $3.67B and its 3Y-monthly beta is at 0.86. It has posted earnings per share of -$1.62 in the same period. It has Quick Ratio of 0.94. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BHC, volatility over the week remained 6.08% while standing at 3.62% over the month.

Analysts are in expectations that Bausch Health Companies Inc (BHC) stock would likely to be making an EPS of $0.69 in the current quarter, while forecast for next quarter EPS is $0.96 and it is $3.99 for next year. For the current quarter EPS, analysts have given the company a lowest target $0.59 which is $0.85 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $0.52 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 12.80% while it is estimated to increase by 1.98% in next year. EPS is likely to shrink at an annualized rate of 2.60% for next 5-years, compared to annual growth of 32.76% made by the stock over the past 5-years.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Jefferies on September 20, 2023 offering a Buy rating for the stock and assigned a target price range of between $9 and $16 to it. On July 29, 2022, Truist Downgrade their recommendations, while on July 29, 2022, RBC Capital Mkts Downgrade their ratings for the stock with a price target of $5. Stock get a Neutral rating from JP Morgan on July 28, 2022.

Most Popular

Related Posts